Deseret Mutual Benefit Administrators lowered its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 2.4% during the third quarter, Holdings Channel reports. The institutional investor owned 4,897 shares of the company’s stock after selling 119 shares during the period. Deseret Mutual Benefit Administrators’ holdings in Colgate-Palmolive were worth $508,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its position in shares of Colgate-Palmolive by 27.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after acquiring an additional 8,933,912 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in shares of Colgate-Palmolive by 40.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after purchasing an additional 2,593,313 shares in the last quarter. Legal & General Group Plc lifted its position in shares of Colgate-Palmolive by 0.8% during the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock worth $755,465,000 after buying an additional 61,413 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd boosted its stake in Colgate-Palmolive by 4.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after buying an additional 278,150 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its holdings in shares of Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock worth $551,367,000 after acquiring an additional 2,955,442 shares during the last quarter. 80.41% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the stock. Evercore ISI raised their target price on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. Sanford C. Bernstein increased their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Wednesday. Hsbc Global Res downgraded Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. Finally, Bank of America raised their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $105.11.
Insider Activity at Colgate-Palmolive
In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.37% of the stock is currently owned by company insiders.
Colgate-Palmolive Price Performance
Colgate-Palmolive stock opened at $90.16 on Thursday. The company has a market cap of $73.66 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 3.33 and a beta of 0.42. The business’s 50 day simple moving average is $101.49 and its 200 day simple moving average is $98.39. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12 month low of $74.67 and a 12 month high of $109.30.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- What is the Australian Securities Exchange (ASX)
- 2 Reasons To Like Coinbase After The Election, 1 to Still Avoid
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Hunting for High-Yield Bargains? 2 REITs to Consider
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Fiserv Is Up 50% This Year and Can Go Another 50% Higher
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.